These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 4585170)

  • 1. Prediction of pharmacological activity by the method of physicochemical-activity relationships.
    Goodford PJ
    Adv Pharmacol Chemother; 1973; 11():51-97. PubMed ID: 4585170
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of hydrophobicity in the antiserotonin activity of LSD analogs.
    Dunn WJ; Bederka JP
    Res Commun Chem Pathol Pharmacol; 1974 Feb; 7(2):275-85. PubMed ID: 4818374
    [No Abstract]   [Full Text] [Related]  

  • 3. Parameter and structure-activity data bases: management for maximum utility.
    Leo A
    Environ Health Perspect; 1985 Sep; 61():275-85. PubMed ID: 4065069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [MASCA-model of the biochemical-pharmacological drug research/part 1: Principle of the univariate structure-activity relationship and definitions of physico-chemical parameters (author's transl)].
    Mager PP
    Arzneimittelforschung; 1975 Jul; 25(7):1006-8. PubMed ID: 1174406
    [No Abstract]   [Full Text] [Related]  

  • 5. [Prospects for the development of methods of predicting safe substance levels based on "structure-activity" relationships].
    Krasovskiĭ GN; Egorova NA
    Vestn Akad Med Nauk SSSR; 1980; (7):88-95. PubMed ID: 6998177
    [No Abstract]   [Full Text] [Related]  

  • 6. Theoretical approaches to drug design and biological activity: critical comments to the use of mathematical methods applied to univariate and multivariate quantitative structure-activity relationships (QSAR).
    Mager PP
    Med Res Rev; 1982; 2(1):93-121. PubMed ID: 7109783
    [No Abstract]   [Full Text] [Related]  

  • 7. [Current problems in drug research. I. Determination of the quantitative structure-activity relationships of biosubstances: theoretical principles, accomplishments, assumptions and present state].
    Franke R; Oehme P
    Pharmazie; 1973 Aug; 28(8):489-508. PubMed ID: 4131698
    [No Abstract]   [Full Text] [Related]  

  • 8. Physicochemical effects in the representation of molecular structures for drug designing.
    Gasteiger J
    Mini Rev Med Chem; 2003 Dec; 3(8):789-96. PubMed ID: 14529498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Main component method in hygienic research on polymeric materials].
    Bol'shakov AM; Tararin VV; Estrov VB
    Gig Sanit; 1981 Sep; (9):54-7. PubMed ID: 7297878
    [No Abstract]   [Full Text] [Related]  

  • 10. Structure-activity correlations of antimalarial compounds. 2. Phenanthreneaminoalkylcarbinol antimalarials.
    Craig PN; Hansch CW
    J Med Chem; 1973 Jun; 16(6):661-7. PubMed ID: 4714998
    [No Abstract]   [Full Text] [Related]  

  • 11. The use of multivariate statistics in industrial pharmacology.
    Lewi PJ
    Pharmacol Ther B; 1978; 3(4):481-537. PubMed ID: 366629
    [No Abstract]   [Full Text] [Related]  

  • 12. Structure-activity correlations of anticancer agents: diaminopyrimidines, N-acyltriamines, bis-(1-aziridinyl)-phosphinyl carbamates, and aromatic nitrogen mustards.
    Lien EJ; Tong GL
    Cancer Chemother Rep; 1973; 57(3):251-61. PubMed ID: 4796118
    [No Abstract]   [Full Text] [Related]  

  • 13. Physicochemical-activity relationships in asymmetrical analogues of methoxychlor.
    Goodford PJ; Hudson AT; Sheppey GC; Wootton R; Black MH; Sutherland J; Wickham JC
    J Med Chem; 1976 Oct; 19(10):1239-47. PubMed ID: 994155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between pharmacological activity indices and quantum chemical indices of some phenylethylamine derivatives.
    Lukovits I; Biczó G; Pataki I
    Experientia Suppl; 1976; 23():165-70. PubMed ID: 954931
    [No Abstract]   [Full Text] [Related]  

  • 15. Obscure phenomena in statistical analysis of quantitative structure-activity relationships. Part 1: Multicollinearity of physicochemical descriptors.
    Mager PP; Rothe H
    Pharmazie; 1990 Oct; 45(10):758-64. PubMed ID: 2089387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the structure of medicinal chemistry.
    Hansch C
    J Med Chem; 1976 Jan; 19(1):1-6. PubMed ID: 1246029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aqueous chlorination and ozonation studies. I. Structure-toxicity correlations of phenolic compounds to Daphnia magna.
    Kopperman HL; Carlson RM; Caple R
    Chem Biol Interact; 1974 Oct; 9(4):245-51. PubMed ID: 4430014
    [No Abstract]   [Full Text] [Related]  

  • 18. Molecular hysteresis and its cybernetic significance.
    Neumann TE
    Angew Chem Int Ed Engl; 1973 May; 12(5):356-69. PubMed ID: 4200277
    [No Abstract]   [Full Text] [Related]  

  • 19. [Physicochemical model for assessing the transformations and carcinogenic activity of polycyclic hydrocarbons].
    Paal'me LP; Kirso UE; Karu TI; Gubergrits MIa
    Vopr Onkol; 1975; 21(10):56-62. PubMed ID: 1189352
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pressing problems of pharmacokinetics].
    Lakin KM; Krylov IuF; Gor'kov VA
    Farmakol Toksikol; 1980; 43(1):5-16. PubMed ID: 6991282
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.